Miroslaw Banasik
Overview
Explore the profile of Miroslaw Banasik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mizera J, Pondel M, Kepinska M, Jerzak P, Banasik M
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941645
Artificial intelligence is rapidly advancing within the domains of medicine and transplantology. In this comprehensive review, we provide an in-depth exploration of current AI methodologies, with a particular emphasis on...
2.
Golebiowski M, Chumadevska M, Kusztal M, Banasik M, Golebiowski T
Case Rep Nephrol Dial
. 2025 Jan;
15(1):9-14.
PMID: 39845264
Introduction: A common complication of arteriovenous fistula (AVF) is thrombosis in the venous segment, which can impair vascular access unless a successful thrombectomy is performed. Case Presentation: In this manuscript,...
3.
Szymczak M, Heidecke H, Zabinska M, Janek L, Wronowicz J, Kujawa K, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768675
Anti-ETAR (endothelin A receptor) antibodies and anti-CXCR3 (C-X-C motif chemokine receptor 3) antibodies are types of non-HLA (human leukocyte antigens) antibodies that could have some influence on the course of...
4.
Golebiowski M, Kusztal M, Szymczak M, Konieczny A, Banasik M, Janczak D, et al.
J Vasc Surg Cases Innov Tech
. 2024 Nov;
10(6):101635.
PMID: 39497931
The purpose of this manuscript is to describe the clinical course of a 66-year-old patient with chronic kidney disease due to focal segmental glomerulosclerosis in whom an access arteriovenous fistula...
5.
Rakotoarison A, Kepinska M, Konieczny A, Wladyczak K, Janczak D, Halon A, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458006
The endothelin system is reported to play a significant role in glomerular and tubulointerstitial kidney disease. In the kidney, endothelins are produced in mesangial cells and the glomerular basement membrane...
6.
Siwy J, Keller F, Banasik M, Peters B, Dudoignon E, Mebazaa A, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335603
Background/objectives: Survival prospects following SARS-CoV-2 infection may extend beyond the acute phase, influenced by various factors including age, health conditions, and infection severity; however, this topic has not been studied...
7.
Szymczak M, Heidecke H, Zabinska M, Rukasz D, Wisnicki K, Kujawa K, et al.
Arch Immunol Ther Exp (Warsz)
. 2024 Aug;
72(1).
PMID: 39166802
We evaluated the concentration of AT2R antibodies in 136 patients with primary and secondary glomerular diseases: membranous nephropathy (n = 18), focal and segmental glomerulosclerosis (n = 25), systemic lupus...
8.
Halloran P, Madill-Thomsen K, Bohmig G, Bromberg J, Budde K, Barner M, et al.
Am J Transplant
. 2024 Aug;
25(1):72-87.
PMID: 39117038
Most kidney transplant patients who undergo biopsies are classified as having no rejection based on consensus thresholds. However, we hypothesized that because these patients have normal adaptive immune systems, T...
9.
Wisnicki K, Donizy P, Kuriata-Kordek M, Uchmanowicz I, Zachcial J, Halon A, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064305
(1) : Kidney transplantation is the best therapy for patients with end-stage renal disease, but the risk of rejection complicates it. Indoleamine 2,3-dioxygenase 1 (IDO1), an enzyme involved in immune...
10.
Krol-Kulikowska M, Banasik M, Kepinska M
Antioxidants (Basel)
. 2024 Jul;
13(7).
PMID: 39061907
Background: Nitric oxide synthase (NOS) is an enzyme that catalyzes the formation of nitric oxide (NO), the altered production of which is characteristic of diabetic nephropathy. NOS exists in three...